MELVILLE, N.Y. -
March 19, 2024 -
PRLog -- Remote Medical Technologies (RMT) believes there is a better way to reliably improve telepathology workflows that significantly benefit patients and doctors and improve the profitability model of medical organizations. This ideology is evident in the latest unveiling of
rmtConnectPlus™ for Telepathology, which RMT will demonstrate at the United States and Canadian Association of Pathology (USCAP) Annual Meeting held in Baltimore from March 25th to the 28th. RMT is exhibiting this newest solution with both their Remote Robotic Controlled (RRC) Microscope mounted onto a purpose-built height adjustable mobile cart (ideal for rapid on-site evaluations)
as well as a Non-Robotic Solution equipped with 4K imaging, which is undoubtedly a perfect alternative for multi-headed microscope use.
RMT drastically reduces time and enhances Rapid On-Site Evaluations (ROSE) assessments and cytology workflows. To further reduce time, RMT now offers the
CellSolutions F50 device as part of its turnkey
rmtConnectPlus™ solution. The
F50 device is a compact instrument that could replace the making of multiple smears by giving a clear, clean cytology slide, without centrifugation or fixation steps, in 20 seconds. Cytotechs and lab techs can reduce the time needed to prepare slides by utilizing the F50 device for immediate remote assessments. Remote cytopathology has never been easier or faster.
RMT has redefined the "rapid" in ROSE. They understand that clinicians are looking to easily and quickly make life-saving decisions based on the highest performance and quality of secure live-dynamic images. RMT aims to provide the next level of security, enhanced high performance, and an elegant user interface.
rmtConnectPlus™ delivers just that. This highly secure telepathology solution for real-time decision-making is compatible with PCs, Macs®, iPhones®, iPads®, and Android devices. With the fastest and highest quality imaging, RMT users can achieve the next level in a safe, unified telepathology approach for Rapid On-Site Evaluations (ROSE) for cytopathology and frozen section requirements.
rmtHealthCheck™ functionality has been a sought-after feature among IT Directors and clinicians in major blue-chip medical facilities nationwide. RMT immediately alerts end users of any potential network disruption that may impede an assessment for upcoming procedures. Founder & CEO Don Marchon explains, "Clinicians and IT staff must be comfortable knowing that the system is always ready, available, and operational. RMT's ability to prewarn all team members of a hospital IT issue that requires immediate resolution has shown beyond doubt to be a unique and valued capability. The
rmtHealthCheck™ technology is proven to help medical centers realize the best uptime performance in the industry."
rmtConnectPlus™ provides the foundation for subsequent standard feature updates such as Chat, enhanced self-administration for unique medical center policies, and preemptive health-checking capabilities to alert users of a potential problem for required resolution before an assessment. These significant RMT system developments will maximize the speed, quality, system uptime availability, and volume of assessments in delivering unprecedented patient outcomes and clinician productivity.
RMT remains ahead of the times and continues to prove they are the leader in state-of-the-
art remote telepathology technologies with their latest, fastest, and proven platform rollout of
rmtConnectPlus™ solution.
Visit RMT at
Booth #945 and get a hands-on demonstration of how Remote Robotic Controlled Microscopes paired with or without a mobile cart for ROSE can significantly improve daily operations at your medical facility. Contact RMT at 855-867-3034 or
https://www.rmtcentral.com/contact-us.
Account Phone Number